Completed Access to Information Requests

About this information

Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).

If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.

*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.

Download datasets of the summaries of completed access to information requests.

Current Search

Report Type

Organization

Disposition

Year

Month

Found 24 record(s)

Req # AF-2023-00073

All emails, texts, phone logs, and written communications between CMHC staff and staff of the City of Kingston, i.e. CAO Lanie Hurdle, Commissioner Paige Agnew, Director of Planning Tim Park, Strategic Director, Craig Desjardins – and with the Mayor and the Mayor’s office -- concerning the Housing Accelerator Fund and the City’s grant application(s) from March 1, 2023 to midnight, December 1, 2023.

Organization: Canada Mortgage and Housing Corporation

81 page(s)
February 2024

Req # A-2024-54596

Submission of the Public Health Agency of Canada (PHAC) to the Patented Medicine Prices Review Board’s November 2023 consultation on the Scoping paper of the Board's Guidelines. Submissions from other stakeholders can be viewed here: https://www.canada.ca/en/patented-medicine-prices-review/services/consultations/scoping-paper-board-guidelines.html

Organization: Patented Medicine Prices Review Board Canada

7 page(s)
February 2024

Req # AF-2022-00035

In 2021 the CMHC provided a sizable grant under its National Housing Strategy's Demonstrations Initiative to the project: Fairbnb and the Kensington Market Community Land Trust. We are also seeking all correspondence between the CMHC and Fairbnb, all correspondence between the CMHC and the Kensington Market Community Land Trust . Finally we are seeking any and all evaluations of the progress of this project done since the grant was provided as well as any receipts or documents outlining the funds provided to the organizations. Time frame: November 1, 2021 to October 6, 2022.

Organization: Canada Mortgage and Housing Corporation

111 page(s)
February 2023

Req # A-2023-02395

Copies of all correspondence and communications between the (then) acting chairperson of the Patented Medicines Prices Review Board Mélanie Bourassa-Forcier and Innovative Medicines Canada (IMC) between October 1, 2022 and December 5, 2022 regarding the PMPRB's new draft guidelines and the consultation process. Please include all responses to Innovative Medicines Canada (IMC)'s communications/correspondence from the (then) acting chairperson of the Patented Medicines Prices Review Board Mélanie Bourassa-Forcier.

Organization: Patented Medicine Prices Review Board Canada

19 page(s)
February 2023

Req # A-2022-09063

Copies of any emails sent by the Vice-chair regarding any of the following topics: (i) her resignation or intent to resign or the reasons for her resignation. (ii) the draft guidelines. (iii) the consultation process for the draft guidelines. (iv) the impact of the Merck Canada, IMC, and/or Alexion court decisions on the PMPRB, including its draft guidelines. From November 1, 2022 to December 5, 2022.

Organization: Patented Medicine Prices Review Board Canada

58 page(s)
February 2023

Req # A-2022-09228

All correspondence between PMPRB Board members and PMPRB staff pertaining to the October 2022 revised draft Guidelines and the resignation of the PMPRB Acting Chairperson, Mélanie Bourassa-Forcier. “Correspondence” includes written correspondence, call notes, email, text messaging, instant messaging, and any other form of electronic communication.

Organization: Patented Medicine Prices Review Board Canada

134 page(s)
February 2023

Req # A-2022-09229

All correspondence between the former PMPRB Acting Chairperson, Melanie Bourassa-Forcier, and the Minister of Health Jean-Yves Duclos (including the Minister’s staff), or Deputy Minister of Health Stephen Lucas (including the Deputy Minister’s staff), about the PMPRB October 2022 revised draft Guidelines and the resignation of PMPRB Acting Chairperson, Melanie Bourassa-Forcier. “Correspondence” includes written correspondence, call notes, email, text messaging, instant messaging, and any other form of electronic communication.

Organization: Patented Medicine Prices Review Board Canada

10 page(s)
February 2023

Req # A-2022-09230

All correspondence between PMPRB Executive Director Doug Clark and the Minister of Health Jean-Yves Duclos (including the Minister’s staff), or Deputy Minister of Health Stephen Lucas (including the Deputy Minister’s staff), about the PMPRB October 2022 revised draft Guidelines and the resignation of PMPRB Acting Chairperson, Melanie Bourassa-Forcier. “Correspondence” includes written correspondence, call notes, email, text messaging, instant messaging, and any other form of electronic communication.

Organization: Patented Medicine Prices Review Board Canada

11 page(s)
February 2023

Req # A-2022-09231

Copies of all PMPRB Board minutes and materials (briefing materials, presentations, staff recommendations) pertaining to the October 2022 revised draft Guidelines.

Organization: Patented Medicine Prices Review Board Canada

37 page(s)
February 2023

Req # A-2022-09622

All correspondence and emails from the federal Health Minister Jean-Yves Duclos to the Patented Medicines Prices Review Board in the period between October 1, 2022 and December 5, 2022 regarding new draft guidelines and the consultation process and all responses to the federal Minister of Health and Health Canada from the (then) acting chairperson of the Patented Medicines Prices Review Board Mélanie Bourassa-Forcier.

Organization: Patented Medicine Prices Review Board Canada

9 page(s)
February 2023
Date modified: